NCT06866041View on ClinicalTrials.gov

Biological Markers and Advanced Imaging for Prostate Cancer Progression in Active Surveillance

NARecruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

May 7, 2025

Primary Completion Date

May 7, 2028

Study Completion Date

March 31, 2030

Conditions
Low-Risk Prostate Cancer
Interventions
PROCEDURE

mpMRI-targeted confirmatory biopsy

mpMRI-targeted confirmatory biopsy after one year from the diagnosis, according to the international guidelines

Trial Locations (1)

20132

RECRUITING

IRCCS Ospedale San Raffaele, Milan

All Listed Sponsors
lead

Università Vita-Salute San Raffaele

OTHER